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The role of interleukins in B  cell activation has been investigated in several 
experimental systems (1-7).  At least with regard to proliferation and the gener- 
ation of antibody-secreting cells, the nonspecific factors were without apparent 
effects on  resting B  cells,  while they amplified responses  of B  cells previously 
"activated" by exposure  to mitogens, anti-immunoglobulin (Ig) 1 antibodies,  or 
antigen-specific/h-restricted helper T  cell signals. Based on these observations, 
models have been developed in which the targets of iymphokines are B cells that 
have previously encountered specific antigen, which presumably induces expres- 
sion or activates receptors for the relevant lymphokines. 
These models of B cell activation parallel more definitive studies with T  cells, 
where it has been demonstrated that mitogen or antigen/MHC activation of T 
cells leads to the expression of receptors for interleukin-2 (IL-2) rendering the 
cell sensitive to its growth-promoting effects (8,  9).  Supporting the application 
of these observations to B cells is the finding that monoclonal antibodies directed 
against the IL-2 receptor complex detect its presence on the surface of B  cells 
activated with lipopolysaccharide (LPS), but not on normal resting cells (9). The 
question that arises is whether these findings apply to the effects of interleukins 
on B cells in general or only to specific cases. 
Numerous studies have demonstrated the importance of Ia in T  cell collabo- 
ration with B cells in the generation of antibody responses (10-12). The require- 
ment for I  region identity may directly reflect requirements for delivery of an 
antigen-specific/I region-restricted helper T  cell signal and indirectly the ability 
of B cells as well as macrophage (M4~) to present antigen to T  cells in an MHC- 
restricted manner,  leading to their production of B cell helper factors (3,  13- 
17).  In  this  regard  some  studies  have  indicated  that  the  level  of  B  cell  Ia 
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expression may be important to the efficiency with which T-B interactions occur 
(18,  19). 
The level of Ia expression on normal B cells is very heterogeneous and may in 
part  reflect the  maturational  state of the cells (20,  21).  While the  mechanisms 
controlling the  level of Ia expression remain  unknown,  it has been established 
that B cell receptor cross-linking with anti-Ig antibodies will induce increased Ia 
expression both  in  vitro and  in  vivo (22,  23).  Macrophage-derived monokines 
have also been implicated in the induction of Ia expression on density-fraction- 
ated bone marrow cells (24). 
The evidence presented in this paper demonstrates that the level of Ia expres- 
sion on normal resting B cells can be profoundly increased following exposure 
to T  cell- and M4~-derived interleukins,  with kinetics similar to those seen with 
membrane Ig cross-linking agents. These observations suggest that receptors for 
these  interleukins  are  expressed  on  resting  B  cells  and  their  effects  can  be 
observed  in  the  absence  of secondary  signals  delivered  by  ligand-receptor  Ig 
interactions and cognate T  cell-B cell interactions. 
Materials and Methods 
Mice.  B6D2F1 mice were bred in our facility from breeding stock obtained from The 
Jackson Laboratory, Bar Harbor, ME. 
Antigens and Other Reagents.  Alpha-methyl-D-mannoside, chicken ovalbumin (cOVA), 
glutaraldehyde,  hydroxyurea,  lysine,  and  sodium  azide  were  purchased  from  Sigma 
Chemical Co., St.  Louis,  MO; and concanavalin A  (Con A) was purchased from Miles 
Laboratories, Inc., Elkhart, IN. 
Trypsin (TPCK-treated, Worthington Biochemical Co., Freehold, N  J) digested cOVA 
was prepared as previously described (25). 
B Cell Preparation.  2-4 d before sacrifice, mice were given an intraperitoneal injection 
of 0.4  ml  of a  1:10  dilution  of rabbit  anti-mouse  thymocyte serum  (Microbiological 
Associates,  Walkersville, MD). Spleen cell suspensions prepared from these mice in Hank's 
balanced salt solution (HBSS) were passed over Sepbadex G10 columns (26), treated with 
a cocktail of antibodies for 30 min on ice, washed with HBSS, and then incubated with a 
1:15 dilution of rabbit serum as the complement source (Grand Island  Biological Co., 
Grand Island, NY) for 30 min at 37°C. The antibody cocktail was similar to that previously 
described (27) containing: B cell-absorbed rabbit anti-mouse thymocyte serum, T24/40.7 
anti-Thy-1 monoclonal antibody (Dr. Ian Trowbridge, Salk Institute, La Jolla, CA),  MK 
2.2  anti-"Qa-[ike"  monoclonal antibody,  B16/146  anti-Qat-4  ascitic  fluid  (Dr.  Ulrich 
Hammerling, Sloan-Kettering Memorial Cancer Institute,  New York,  NY),  ADH4(15) 
anti-Lyt-2.2 ascites fluid (Dr.  Paul Gottlieb, University of Texas, Austin, TX), and GK 
1.5 anti-L3T4 monoclonal antibody (Drs. Deno Dialynas and Frank Fitch, The University 
of Chicago, Chicago, IL). Following antibody plus complement treatment the erythrocytes 
were lysed by treatment with ammonium chloride and viable cells enriched by centrifuga- 
tion over Ficoll-hypaque (28). 
B Cell Culture for la Induction.  1 x  106 T  cell- and M4~-depleted splenic B cells were 
cultured in 0.5 ml complete medium in  Linbro 76-033-05 24-well  culture plates (Flow 
Laboratories, Inc., McLean, VA). Culture conditions were modified from those of Mishell 
and  Dutton  (29,  30).  Cultures contained:  10  mg/ml  a-methyl-D-mannoside to prevent 
effects of residual Con A  in nonspecific factor preparations and 2 mM hydroxyurea to 
inhibit DNA synthesis and cell division. All cultures contain 5% fetal bovine serum, from 
a lot selected for its ability to support in vitro anti-sheep erythrocyte plaque-forming cell 
responses with low backgrounds in control cultures.  Interleukin-induced increases in B 
cell Ia expression of comparable magnitude have also been observed at fetal bovine serum 
concentrations of 0.01% (data not shown). 
Nonspecific Factor Preparations.  Macrophage-derived helper factors were obtained as ROEHM  ET  AL.  681 
the constitutive culture supernatant (SN) of the M4~ tumor cell line P388D~  (P388  SN) 
(31).  P388D~ were cultured at 2 ×  106 cells/ml in complete medium containing 1% fetal 
bovine serum. After 6 d of culture the cell free SN was harvested and stored at -20°C. 
This factor preparation has previously been shown to enhance the primary in vitro anti- 
sheep erythrocyte plaque-forming cell response of M4~- and T cell-depleted splenic B cells 
(32). 
An  IL-2 and  B  cell  growth  factor (BCGF)  containing  SN  were  prepared from the 
mycoplasma free T  cell hybridoma FS6-14.13  as previously described (FS6 Con A SN) 
(27,  33).  FS6-14.13  at  106 cells/ml in complete medium containing  0.5%  fetal bovine 
serum, were stimulated with 3 ~g/ml Con A for 24 h. Based on the method of Watson et 
al. (34), the cell-free SN was made 0.1  M with a-methyl-D-mannoside and then (NH4)2SO4 
added to 40% saturation. The resulting precipitate was discarded and (NH4)2SO4 added 
to 80%  saturation.  The second precipitate was resuspended in  0.15  M  NaCI and then 
extensively dialyzed against 0.15 M NaCI and then against HBSS. The final concentration 
of the factor preparation was ~50× the original SN. 
Gel filtration of FS6 Con A SN was performed using a  2.5  ×  100 cm Sephadex G75 
(Pharmacia Fine Chemicals, Uppsala, Sweden) column equilibrated with 0.1  M ammonium 
bicarbonate. 5 ml of FS6  Con A SN  was applied to the column and eluted with 0.1  M 
ammonium bicarbonate. 10-ml fractions were collected, frozen, and lyophilized to remove 
water and  ammonium bicarbonate.  The  elution  profile (molecular weight  vs.  elution 
volume) of human gamma globulin, bovine serum albumin, chicken ovalbumin, chymo- 
trypsin, myoglobin, and cytochrome c was used as a calibration standard. 
Immunofluorescence Staining.  After 24 h of culture the cells were washed in phosphate- 
buffered saline containing 1% fetal bovine serum and 0.2% sodium azide. The cells were 
then incubated with an appropriate dilution of a biotin-conjugated monoclonal anti-I-A  b'd 
antibody D3.137.5.7  (Dr.  Sue  Tonkonogy, North  Carolina State  University School of 
Veterinary Medicine, Raleigh, NC) at 4°C for 20 min, at a cell concentration of 107/ml. 
The cells were then washed twice and incubated at 4 °C for 20 min with a  1:100 dilution 
of fluoroscein-conjugated avidin (Vector Laboratories, Burlingame, CA). The cells were 
then washed twice and resuspended at  106/ml for analysis. The D3.137.5.7  monoclonal 
antibody was affinity purified by adsorption and elution from a staphylococcal protein A- 
Sepharose column. The resulting antibody was biotin conjugated using N-hydroxysucci- 
nimidobiotin (Sigma Chemical Co., St. Louis, MO) (35). 
Cytofluorometric Analysis.  The relative fluorescence intensities of individual cells were 
measured using the Cytofluorograf System 50H (Ortho  Diagnostic Instruments, West- 
wood, MA) equipped with a 5W argon laser. Forward narrow angle light scatter was used 
as a  second parameter to facilitate exclusion of dead or aggregated cells from analysis. 
Fluorescence intensity data is presented as the log of integrated fluorescence. 
Acridine Orange (AO) Cell Cycle Analysis.  The staining procedure of Darzynkiewicz et 
al. (36, 37) was used throughout this study. This procedure involves incubation of cells, 
after mild EDTA-detergent treatment at low pH (0.1% Titron X-100, 1 mM EDTA, 0.1 
N HCI, pH 3.8) with an aqueous solution of AO (13 #M). Due to the differential binding 
characteristics of AO to single- and double-stranded nucleic acids, DNA fluoresces green 
while RNA fluoresces red upon excitation by 488 nm laser light. Relative integrated red 
and green fluorescence were determined using the Cytofluorograf  System 50H in standard 
configuration. 
Cells that were dead before analysis were excluded from the assay based upon integrated 
forward light scatter and integrated  green (DNA) fluorescence. Aggregated cells were 
discriminated and excluded based upon the ratio of peak green fluorescence and area of 
green fluorescence. To determine the proportion of cells that had entered cycle, histo- 
grams depicting relative red fluorescence (RNA) were constructed and integrated. 
Preparation of Anti-Fab.  Rabbit anti-mouse Ig was raised by subcutaneous injection of 
100 ~g of Fab fragments of normal mouse Ig in complete Freund's adjuvant. Anti-Fab 
antibodies were affinity purified using normal mouse IgG-Sepharose and eluted using 3.5 
M MgCI~. The resulting antibody was passed over a staphylococcal protein A-Sepharose 
column.  The  bound  protein  was  eluted  with  0.1  M  sodium  acetate,  pH  4.3.  Pepsin 682  INTERLEUKIN-INDUCED  INCREASE IN  B CELL  la  EXPRESSION 
digestion of the resulting anti-Fab antibody was accomplished using standard methods 
(38).  Purified F(ab')2 fragments were isolated by passing the neutralized digest over the 
staphylococcal protein A-Sepharose column, which retained the undigested Ig. 
BCGF Assay.  The assay for BCGF was similar to that previously described (6). B cells 
were prepared as described above and cultured at 7.5 ×  104/well  in 96-well microtiter 
culture plates (Flow Laboratories, McLean, VA) using complete Mishell-Dutton medium. 
Triplicate cultures containing serial dilutions of the putative BCGF containing SN were 
stimulated for 72 h with  10 #g/ml rabbit F(ab')~ anti-mouse Ig (not affinity purified) in 
the presence of 20% P388 SN and 10 mg/mi a-methyl-D-mannoside. Cultures were then 
pulsed with [3H]thymidine for 4 h and incorporation determined by liquid scintillation 
counting. 
Assay oflL-2 Activity.  The T  cell growth-stimulating activity of IL-2 was assayed as 
previously described  using  the  IL-2-dependent  T  cell  line  HT-2  (16,  25,  27,  33). 
Triplicate cultures containing 100 #1 twofold dilutions of a putative IL-2-containing SN 
received 4,000 viable HT-2 cells. After 24 h the cultures were pulsed with [3H]thymidine 
for 4 h and incorporation was determined by liquid scintillation counting. 
Assay of Antigen Presentation  by B Cells.  The assay for antigen-specific, Ia-restricted B 
cell stimulation of IL-2 production by the T  cell hybridoma DO-11.10 (cOVA/I-A  a) was 
performed as previously described (25, 39).  1 ×  105 DO-11.10 hybridoma T  cells were 
cultured in 96-well microtiter tissue culture plates containing 1 mg/ml native cOVA or 
trypsin-digested, denatured cOVA and the indicated number of B cells in 0.3 ml complete 
medium. Cultures were incubated for 24 h at 37°C, whereupon the presence of IL-2 in 
the culture SN was determined using the IL-2-dependent T  cell line HT-2. IL-2 titers 
were determined by titration of the SN and the first twofold dilution to yield <90% viable 
HT-2 cells upon visual inspection was defined as containing 1 U of IL-2. 
For  fixation,  the  B  cells  were  washed  twice  with  HBSS  and  adjusted  to  a  final 
concentration of 5 ×  106 ceUs/mi  in HBSS. Giutaraldehyde was added to a final concen- 
tration of 0.05%. After 30 min at room temperature, fixation was stopped by addition of 
an equal volume of 0.2 M lysine in HBSS, pH 7.4. The cells were centrifuged and washed 
before use.  Antigen-presenting cells  fixed in  this manner are unable to present native 
cOVA to T  cells, but will present trypsin-digested, denatured cOVA (25). 
Results 
Effects  of Interleukins  on B  Cell Ia  Expression.  Previous studies  have demon- 
strated that the constitutive culture SN of the  M~ tumor cell line P388D1  and 
the  Con  A-induced  culture  SN  of the  T  cell  hybridoma  FS6-14.16  contain 
nonspecific helper factors that amplify B cell proliferative responses induced with 
anti-Ig antibodies  as  well  as  the  generation  of antigen-specific and  polycional 
antibody-secreting cell responses upon appropriate stimulation (27, 32,  33, 40- 
42).  In  each of these systems the nonspecific factor preparations  were without 
apparent effects on B cells when tested alone.  We have now demonstrated that 
interleukins present in  P388  SN  and  FS6  Con A  SN  will directly stimulate  an 
increase in Ia expression on normal resting B cells. 
B6D2FI splenic B cells that were depleted of M4~ (and B cell blasts) by passage 
through Sephadex G 10 columns and rigorously depleted of T  cells by treatment 
with  anti-thymocyte serum  in  vivo and  a  cocktail  of antibodies  in  vitro,  were 
cultured for 24 h  alone or in the presence of P388 SN and/or FS6 Con A  SN. 
After culture  relative Ia  expression  was  determined  by staining  with a  biotin- 
conjugated anti-I-A b'd monoclonal antibody followed by fluorescein-conjugated 
avidin and cytofluorometric analysis. The results of a representative experiment 
are shown in Fig.  1. The level of Ia expression in the control populations of B 
cells was extremely heterogenous, covering nearly three decades. In the presence ROEHM  ET  AL.  683 
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FIGURE  1.  Interleukin-induced increase in B cell Ia expression. Normal splenic B cells were 
cultured for 24 h either alone or in the  presence  of P388  SN and/or FS6 Con A  SN. Cells 
were stained  with biotin-conjugated anti-I-A  e'b monoclonal antibody followed by fluorescein- 
conjugated  avidin  and  analyzed  by  flow  cytometry.  5,000  cells  were  analyzed  for  each 
histogram. 
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FIGURE  2.  Kinetics of interleukin-induced increase in B cell Ia expression. Normal splenic B 
cells were cultured alone (control) or with P388 SN plus FS6 Con A SN. At the indicated time 
points the cells were stained  with biotin-conjugated anti-I-A  b'd monoclonal antibody followed 
by fluorescein-conjugated avidin and then analyzed by flow cytometry. Relative mean fluores- 
ence (Ia) was determined  for each population and expressed as a percentage of the maximum 
response. 
of P388 SN and/or FS6 Con A SN there was a reproducible increase in mean Ia 
expression  of the  B  cell  population  relative  to  the  control.  In  six  consecutive 
experiments the increase in mean Ia expression induced with P388 SN was 4.9 
_+ 0.9, with FS6 Con A  SN  10.7 __+  1.5, and with both preparations  13.0 _  1.7. 
The effects of the two nonspecific preparations in combination were additive at 
best and not synergistic.  Of particular note is the fact that there is only a small 
overlap in the fluorescence intensity of control B cell and cells cultured with FS6 
Con A SN. This result suggests that virtually all B cells, not just a subpopulation 
of the cells were stimulated to increased Ia expression. 
Kinetic Analysis oflncrease in la Expression.  Fig. 2 depicts a kinetic analysis of 
the relative change in mean Ia expression by the B cells. At the indicated time 
points the B  cells were removed from culture, stained  for Ia expression, fixed 684  INTERLEUKIN-INDUCED  INCREASE  IN  B  CELL  Ia  EXPRESSION 
with formaldehyde (3.36%  final),  and stored in  the dark  until  cytofluorometic 
analysis. Control studies demonstrated that this fixation procedure has a minimal 
effect on autofluorescence and immunofluorescent staining.  As shown in Fig. 2 
the combination  of P388  SN and  FS6 Con  A  SN  induced a  rapid  increase  in 
mean Ia expression that was optimal at 24 h of culture. The mean Ia expression 
of the control population remained relatively stable, with only a small drop in Ia 
expression  during  the  culture  period.  Analysis of Ia  expression  was routinely 
conducted at 24 b  of culture.  The stability of Ia expression in control cultures 
and the high viability of recovered cells (generally >90%) suggests that the effects 
of the interleukin  preparations  represent a true increase in B cell Ia expression 
and cannot be explained by selective survival or enrichment of B cells with high 
Ia expression. 
Titration ofP388 SN and FS6 Con A SN.  In an attempt to demonstrate dose- 
response  relationships  for  the  interleukin  preparations,  a  series  of  titration 
experiments were conducted. A representative experiment depicting the relative 
increase in  Ia expression as a  function of the SN volume added per culture is 
shown in Fig.  3. The results established that the log of mean  Ia expression was 
linearly related to the log of the FS6 Con A  SN or the P388 SN volume added 
per culture. 
Relationship  between Cell  Cycle State  and  Increased  la  Expression.  We  next 
examined  the  effects of F(ab')2  anti-Ig  antibodies  and  the  nonspecific  factor 
preparations on increased la expression and entry into cell cycle. Entry into G] 
was assessed by changes  in  RNA content  (red fluorescence) following staining 
with AO. To quantitate the proportion of cells that had entered cycle, histograms 
relating  cell  frequency  to  red  fluorescence  (RNA)  were  constructed  (Fig.  5). 
Those cells containing  elevated  red  fluorescence intensity  to  the  right  of the 
channel marker were considered to have entered G]. These results are presented 
in  Table  II.  Table  I  lists the  mean  Ia expression of the  B cells relative to the 
control which did not receive anti-Ig or factors. Histograms depicting the profile 
of Ia expression from the four corner groups of Table I are shown in Fig. 4 and 
histograms depicting RNA content from these same groups in Table II are shown 
in Fig. 5. 
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FIGURE 3.  Dose-response relationship of interleukin-induced increase in B cell la expression. 
Normal splenic B cells were cultured in 0.5 ml medium containing the indicated volume of 
P388 SN or FS6 Con A  SN.  At 24 h  of culture cells were stained for surface la expression 
using biotin-conjugated anti-I-A  b'd monoclonal antibody, followed by fluorescein-conjugated 
avidin and analyzed by flow cytometry. Relative mean fluorescence (Ia) of each population is 
presented. ROEHM  ET  AL. 
TABLE  I 
Relationship between Cell Cycle State and Increased Ia Expression: 
Relative Mean Fluorescence (Ia) of B Cells Cultured with the 
Indicated lnterleukin  Preparations and/or Anti-lg 
Culture SN added 
F(ab')~ anti-mouse Ig (#g/ml) 
None  0.2  1.0  5.0 
None  1.0  1.0  1.9  3.9 
P388 SN (A)  4.3  4.7  7.1  10.2 
FS6 Con A SN (B)  11.1  12.3  15.4  18.2 
A +  B  13.9  15.5  16.5  18.9 
685 
TABLE  II 
Relationship between Cell Cycle State and Increased Ia Expression: 
Percentage of Cells Entering Gl as Determined by Red Fluorescence 
following Staining with AO* 
Culture SN added 
F(ab')~ anti-mouse Ig (pg/ml) 
None  0.2  1.0  5.0 
None  5.1  I 0.5  19.5  43.9 
P388 SN (A)  17.5  22.2  45.3  53.8 
FS6 Con A SN (B)  12.7  21.7  49.2  64.0 
A +  B  27.4  38.4  68.8  79.3 
* See Fig. 5. 
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FIGURE 4.  F(ab')~ anti-mouse Ig and interleukin-induced increase in B cell  Ia expression. 
Normal splenic B cells were cultured either alone or with 5.0 pg/ml rabbit F(ab')~ anti-mouse 
Ig and/or P388 SN plus FS6 Con A SN. At 24 h of culture cells were stained for membrane 
Ia expression and analyzed by flow cytometry. 5,000 cells were analyzed for each histogram. 
(See Table I for relative mean fluorescence of each population). 
As previously demonstrated (22, 23, 43), F(ab')~ anti-Ig antibodies stimulated 
both increased  Ia expression and entry into Gl as indicated by increased RNA 
content. The addition of P388 SN and/or FS6 Con A SN further increased the 
magnitude of anti-Ig effects in an additive manner.  The factors alone appear to 
stimulate a slight increase in cellular RNA content. 
Two features of these results are of particular interest.  First, the symmetry of 
the histogram depicting RNA content of the control population (Fig. 5) indicates 
that virtually all the cells are in Go, suggesting that the interleukin preparations 686  INTERLEUKIN-INDUCED INCREASE  IN  B  CELL  Ia  EXPRESSION 
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FIGURE 5.  Effect of F(ab')e anti-mouse Ig and interleukins on entry into cell cycle. Histo- 
grams depict relative red fluorescence (RNA content) of normal splenic B cells stained with 
acridine orange  following 24  h  culture either alone or with  5.0  pg/ml  rabbit  F(ab')~ anti- 
mouse Ig and/or P388 SN plus FS6 Con A SN, Each histogram was constructed by analysis  of 
5,000 cells by flow cytometry. Those cells exhibiting greater red fluorescence than the channel 
indicated by the arrow were considered to have entered cycle (see Table II). 
were able to  directly  induce  increased  Ia  expression  on  resting  B  cells in  the 
apparent absence of other activating signals. This conclusion is further supported 
by the  results  when  we  deliberately  tried  to  activate  the  B  cells  with  anti-Ig 
antibodies.  While the anti-Ig antibodies did cause an additional  increase in  the 
level of Ia expression on B cells cultured in the presence of P388 SN and FS6 
Con A SN, the frequency of cells demonstrating increased Ia was not substantially 
higher.  As  compared  to  the  nonspecific  factor  preparations,  F(ab')~  anti-Ig 
antibodies were better able to induce entry into cell cycle, but were less effective 
at  inducing  increased  Ia  expression.  This  dichotomy was even  more apparent 
when the F(ab')2 anti-Ig antibodies were used as a pulse before the initiation  of 
culture (data not shown). 
Analysis  of Active Component(s) of FS6 Con A SN.  Previous studies have estab- 
lished  that  Con  A-induced  culture  SN  of the  T  cell  hybridoma  FS6-14.13 
contain at least two lymphokines, IL-2 and BCGF (44). In an attempt to determine 
whether either of these factors was involved in the induction of increased B cell 
Ia  expression,  FS6  Con  A  SN  was  fractionated  on  a  Sephadex  G75  column. 
Pooled fractions were then assayed for IL-2 activity (using the IL-2-dependent 
T  cell line HT-2),  for BCGF (using splenic B cells stimulated with low doses of 
rabbit F(ab')2 anti-mouse Ig), and  for their ability to induce increased B cell Ia 
expression.  In each case the pooled fractions were titrated and units of activity/ 
milliliter were determined:  1 U of activity was defined as the SN volume required 
to give a  response equal  to one-half the square root of the maximum  response 
multiplied by the background response. The results of this analysis are shown in 
Fig. 6. The bulk of the IL-2 activity appeared in fraction I, corresponding to a 
molecular weight  range  of 35,000  to  58,000.  The  bulk of the  BCGF and  Ia- 
inducing activity appeared in fractions III and IV, corresponding to a molecular 
weight  range  of 9,300  to  26,000.  The  close correlation  between  Ia-inducing 
activity and BCGF activity and the lack of correlation with IL-2 activity suggests 
that  BCGF or an  as  yet  undefined  T  cell  lymphokine  may be responsible for 
inducing increased Ia expression on B cells. 
Role  of IL-2  and  Interferon-gamma  (IFN~) in  Enhanced  B  Cell  Ia  Expres- ROEHM  ET  AL.  687 
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FIGURE 6.  Sephadex G75  column fractionation of FS6 Con A SN, correlation of IL-2, 
BCGF, and Ia inducing activity. A Con A-induced cultured SN of the T cell hybridoma FS6- 
14.13 was fractionated on a Sephadex  G75 column  and fractions  corresponding to the indicated 
molecular weights were then pooled. Each pooled fraction was then titrated for IL-2 (T cell 
growth factor activity using HT-2 cells), BCGF  (proliferation of normal B cells stimulated with 
rabbit F(ab')~ anti-mouse Ig) and Ia inducing activity, each expressed as units of activity/ml. 
sion.  Previous studies have established the ability of IFN~ to induce Ia expres- 
sion by M4) (45, 46). In this regard we tested the ability of murine IFNv, prepared 
by  recombinant  DNA  technology  (kindly  provided  by  Genentech,  Inc.,  San 
Francisco, CA), to induce Ia expression in B cells. In addition we attempted to 
confirm the conclusion that IL-2 was not responsible for the B cell Ia enhancing 
activity of FS6  Con  A  SN  by  testing the  effects of cloned  human  IL-2,  also 
prepared by recombinant DNA technology (kindly provided by David Mark of 
Cetus, Emeryville, CA). 
The results of these studies are shown in Fig.  7.  FS6 Con A  SN was used as 
the positive control and the data were plotted as a function of the units/milliliter 
BCGF activity in this preparation.  Neither the cloned IFNv nor the cloned IL-2 
had detectable B cell Ia-inducing activity at concentrations as high as  1,000  U/ 
ml (units IFNv activity based on inhibition of viral replication and units of IL-2 
based  on  T  cell  growth  factor activity with  HT-2  cells).  The  units  of cloned 
IL-2 used in this experiment exceed the range of IL-2 activity present in  FS6 
Con A  SN.  In addition both  the  cloned IL-2 and cloned  IFN~ failed to have 
effects on  B  cell  Ia expression  at concentrations where  they can  be  shown  to 
amplify the generation of anti-hapten  and anti-sheep erythrocyte antibody re- 
sponses  (plaque-forming  cells)  by  B  cells  prepared  in  an  analogous  manner 
(reference  44  and  unpublished).  These  results  suggest  that  the  induction  of 
increased B cell Ia expression is not mediated by IL-2 or IFN~. 
Induction  of Increased B  Cell Ia Expression  and Its Effect  on Antigen-presenting 
Capacity.  In an attempt to determine whether the interleukin-induced increase 
in B cell Ia expression might influence T-B interactions, we tested the ability of 
induced and control B cells to present antigen to antigen-specific/Ia-restricted T 
cell hybridomas. Fig. 8 depicts a representative experiment. B cells were cultured 
for 24  h  either alone or in  the presence  of P388  SN and FS6  Con A  SN  and 688  1NTERLEUKIN-INDUCED  INCREASE  IN  B  CELL  la  EXPRESSION 
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FIGURE 7.  Effects of cloned human IL-2 and cloned murine IFN~ on B cell la expression. 
Normal splenic B cells were cultured for 24 h either alone, with FS6 Con A SN, cloned human 
IL-2, or cloned murine IFNv. Cells were then stained for surface Ia expression and analyzed 
by flow cytometry. Data are expressed as the relative mean fluorescence (Ia) for each population 
as a function of U/ml of the lymphokine present in culture. U/ml of cloned IL-2 determined 
by T  cell growth factor activity with HT-2  cells;  IFN~ activity based on inhibition of viral 
replication; and  FS6  Con  A  SN activity based on  BCGF activity using anti-Ig stimulated B 
cells. 
then titrated for their ability to present cOVA to  the T  cell hybridoma DO- 
11.10 (OVA/I-Ad). Presentation of antigen was monitored by the production of 
IL-2 by the T  cell hybridoma. The lower panel of Fig.  8 demonstrates that B 
cells  incubated  with  P388  SN  plus  FS6  Con  A  SN  (14-fold  increase  in  Ia 
expression) are more efficient in presenting cOVA to the T  cell hybridoma DO- 
11.10 than the control B cells. Similar results were obtained with three other T 
cell hybridomas, differing in antigen/MHC specificity. 
Clearly, there could be a variety of changes induced by the interleukins that 
might contribute to this increase in antigen-presenting ability. In an attempt to 
eliminate the potential contribution of changes in intracellular antigen-processing 
events, we took advantage of the recent demonstration that glutaraldehyde-fixed 
accessory cells are capable of MHC-restricted presentation of antigens that have 
been "processed" in vitro by chemical or enzymatic degradation (25). As shown 
in the upper panel of Fig.  8  using DO-11.10  and trypsin-digested, denatured 
OVA, the enhanced antigen-presenting capacity of B cells cultured with P388 
SN  plus  FS6  Con  A  SN  relative  to  control cells was also apparent  following 
glutaraldehyde fixation. While this result does not conclusively demonstrate that 
the increase in  Ia expression is causally related to the increase in efficiency of 
antigen presentation, it is consistent with this possibility. 
Discussion 
The data presented in this paper demonstrate that the level of Ia expression 
on normal resting B cells can be dramatically increased by exposure to interleu- 
kins present in the constitutive culture SN of the MO tumor line P388D1  and 
the Con A-induced culture SN of the T  cell hybridoma FS6-14.13. When tested 
individually,  both  these  nonspecific  factor  preparations  increased  B  cell  Ia ROEHM  ET  AL.  689 
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FIGURE 8.  Enhancedantigen-presentingcapacityofnormalBcellsincubatedwithinterleukin 
preparations. Normal splenic B cells were cultured for 24  h  either alone (control) or with 
P388 SN plus FS6 Con A SN (Ia induced). Cultures did not contain hydroxyurea. Relative to 
the control there was a  14x increase in mean fluorescence (Ia) of the B cells incubated with 
the nonspecific factor preparations. The two populations of B cells were then titrated for their 
ability to present cOVA to  the T  cell hybridoma DO-11.10 (cOVA/I-Ad), leading to  the 
production if IL-2. Lower panel: units of IL-2 produced by DO-1 1.10 following stimulation 
with native cOVA and the indicated number B cells (not fixed), upper panel: Units of IL-2 
produced by DO-11.10 following stimulation with trypsin digested, denatured cOVA and the 
indicated number of glutaraldehyde-fixed B cells. 
expression  in  a  dose-dependent  manner and  when  tested  in  combination  at 
subsaturating  concentrations,  their  effects were not  synergistic,  but  additive. 
This  interleukin (P388  SN  +  FS6  Con  A  SN)-induced increase in  surface Ia 
expression was observed to occur in virtually all the B cells, resulting in a  13- 
fold increase (average of 6 consecutive experiments) in relative mean fluorescence 
of the population following staining for surface Ia. 
The ability of the nonspecific factor preparations to induce increases in resting 
B  cell  Ia  expression appeared to  be a  direct effect of the interleukins in  the 
absence of additional  activating signals.  This  conclusion is  supported  by  two 
observations. First, although cell cycle analysis demonstrated that 95% of the B 
cells not exposed  to  the interleukins remained in  Go throughout the  culture 
period, virtually all exhibited increased Ia expression following exposure to the 
interleukin preparations. Second, the rate of interleukin-induced increase in Ia 
expression was extremely rapid, apparently occurring as quickly as new transcrip- 
tion, translation, and expression could occur (47). If an additional signaling event 
were prerequisite for the interleukin effect, one might have expected to see a 
longer lag before the increase in Ia was detectable. 
These  observations  have  important  implications  for  models  regarding  the 690  INTERLEUKIN-INDUCED  INCREASE  IN  B  CELL  Ia  EXPRESSION 
effects of interleukins  on  B  cell  activation.  First,  they  imply  that  functional 
receptors for at least some interleukins exist on the surface of normal resting B 
cells. Second,  that  these interleukins  have direct effects on  B cells (level of Ia 
expression and antigen-presenting capacity) in the absence of ancillary activating 
signals involving ligand-Ig receptor cross-linking.  It is noteworthy in this regard 
that several investigators have described nonspecific T  cell factors that appear to 
directly  activate  normal  resting  B  cells  (48,  49).  The  relationship  of  these 
observations  to  the  effects of FS6  Con  A  SN  on  B  cell  Ia  expression  awaits 
further study. 
The  identity  of the  factors  in  P388  SN  and  FS6  Con  A  SN,  which  are 
responsible for enhancement of B cell Ia expression, have yet to be conclusively 
determined.  The FS6 Con A  SN is known to contain at least two lymphokines, 
IL-2 and  BCGF (44).  Column chromatography  of FS6 Con A  SN suggested a 
correlation  exists  between  BCGF and  the  Ia-inducing  activity on  the  basis  of 
molecular weight.  These two lymphokine activities have also been observed to 
be both qualitatively and quantitatively  correlated in  Con A  SN from other T 
cell sources (data not shown). However, in the absence of a rigorous biochemical 
characterization  it is not possible to definitively establish the nature of the T  cell 
lymphokine involved in enhancing B cell Ia expression. 
The Ia-inducing activity of FS6 Con A SN showed no correlation with IL-2, a 
result that was consistent with the fact that cloned human IL-2 had no effect on 
B cell Ia expression, at concentrations where it could be shown to enhance B cell 
antibody responses (unpublished).  Similarly,  cloned mouse IFNy had  no effect 
on the level of B cell Ia expression, when used at concentrations at which it could 
be shown to amplify B cell antibody responses (46). This latter observation was 
particularly  interesting  in  view  of the  ability  of IFN  v to  induce  enhanced  Ia 
expression  and  antigen-presenting  capacity  in  Mq~  (45,  46).  Our  observations 
suggest that a parallel system exists in B cells, which does not, however, involve 
IFN~. It is unclear at this time whether the interleukin-induced enhancement of 
B cell antigen-presenting  capacity directly reflects the increase in Ia expression 
or whether other surface changes are also involved. 
Historically, supernatants  of P388D~ have been used as a reference source of 
interleukin  1 activity (50). Attempts to demonstrate that a low molecular weight 
(~15,000  daltons)  component  of P388  SN  was  responsible  for  the  B  cell  Ia- 
enhancing  activity  have  been  equivocal.  Sephadex  G75  chromatography  of 
ammonium  sulfate-precipitated  P388  SN  has  demonstrated  as  small  peak  of 
activity with a molecular weight of~ 15,000, however the bulk of activity appears 
in  the  void  volume,  corresponding  to  a  molecular  weight  of >80,000.  It  is 
noteworthy  in  this  regard  that  a  high  molecular  weight  factor  produced  by 
P388D1  has  been  recently  described,  which  induces  Ia  expression  by the  M4~ 
tumor  line  WEHI  3  (51).  Characterization  of the  factor  active  in  our  assay 
systems awaits further study. 
Summary 
The  constitutive  culture  supernatant  (SN)  of the  macrophage  tumor  line 
P388D1 (P388 SN) and the concanavalin A (Con A)-induced culture supernatant 
of the  T  cell  hybridoma  FS6-14.13  (FS6  Con  A  SN) were  shown  to  contain ROEHM ET  AL.  691 
nonspecific factors capable of inducing increased Ia expression by normal resting 
B cells in a  dose-dependent manner. In six consecutive experiments the relative 
increase in Ia expression induced by P388  SN was 4.9 __+ 0.9, with FS6 Con A 
SN  10.7  _+  1.5, and with a  combination of both preparations  13.0  +  1.7.  This 
increase  in  Ia  expression  was  observed  to  occur  in  virtually all  the  B  cells, 
reaching maximum levels within 24 h of culture. 
The  interleukin-induced  increase  in  B  cell  Ia  expression  occurred  in  the 
absence  of ancillary  signals  provided  by  ligand-receptor  Ig  cross-linking and 
despite the fact that virtually all the control B cells, cultured in the absence of 
factors, remained in  Go. These results suggest that functional receptors for at 
least some interleukins are expressed on normal resting B cells and their effects 
can be manifest in the absence of additional activating signals. The increased Ia 
expression  induced  by  the  nonspecific  factor  preparations  was  shown  to  be 
correlated  with  enhanced antigen-presenting capacity by the  B  cells to  T  cell 
hybridomas. 
The  nature  of the  interleukins  responsible  for  these  effects remains  to  be 
definitively determined, however, the activity of FS6 Con A  SN  was shown to 
correlate with B cell growth factor activity and increased B cell Ia expression was 
not  observed  using  interleukin  2  (IL-2)  or  interferon-gamma,  prepared  by 
recombinant DNA technology. 
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